Keyphrases
Activating mutation
16%
Atypical Proliferative Serous Tumor
33%
Borderline Tumor
66%
Carcinoma Progression
16%
Exon 3
16%
Genetic Events
100%
Genetic Modification
16%
Low Prevalence
16%
Mutational Analysis
16%
Mutational Status
16%
Precursor Lesions
16%
RAS Oncogene
16%
RAS Pathway
16%
Biochemistry, Genetics and Molecular Biology
Exon
25%
Gene Mutation
25%
Genetics
100%
KRAS
100%
Oncogene
25%
Precursor
25%
Prevalence
25%
Wild Type
25%
Medicine and Dentistry
Cell Signaling Pathway
12%
Exon
12%
Gene Mutation
12%
Mutational Analysis
12%
Neoplasm
75%
Oncogene
12%
Precursor
12%
Prevalence
12%
Serous Carcinoma
100%
Pharmacology, Toxicology and Pharmaceutical Science
Borderline State
50%
Carcinoma
100%
Neoplasm
75%
Prevalence
12%